Home/ Supplements/ L Arginine/ N.O.max ER

N.O.max ER

product on market Tablet or Pill XYMOGEN Safety: 100/100
100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • Limited research evidence available for ingredients
B Label Compliance Grade
Label

Product Label

Label for N.O.max ER
Open Full PDF View on NIH DSLD →
Details

Label Data

3 Tablet(s)
Serving Size
60
Servings
Other Combinations
Product Type
0%
Evidence Coverage
Ingredients

Supplement Facts — Evidence Check

Market median: 500.0mg (143 products)
ActiNOS
150 mg

Other Ingredients

Hydroxypropyl Methylcellulose Stearic Acid Hydroxypropyl Cellulose Silica Hydroxypropyl Methylcellulose Medium Chain Triglyceride Magnesium Stearate
Claims

Label Claims — Verification

Unverified Nutrient
Unverified All Other
Unverified Structure/Function
Info

Product Information

Directions for Use

Directions: Take three tablets twice per day: 3 tablets 30 minutes before breakfast and 3 tablets again 30 minutes before lunch with 8 ounces of water.

Warnings & Precautions

Cautions: Consult your healthcare professional prior to use, especially if you have or suspect you have a medical condition, including diabetes or cold sores; if you take prescription drugs or are allergic to any ingredient; or if you are pregnant or lactating.

Keep out of reach of children. This product is not intended for use by individuals under 18 years of age.

Do not use if tamper seal is damaged.

Storage: Keep closed in a cool, dry place out of reach of children.

Contains: Milk

Cautions: Consult your healthcare professional prior to use, especially if you have or suspect you have a medical condition, including diabetes or cold sores; if you take prescription drugs or are allergic to any ingredient; or if you are pregnant or lactating.

Formulation Notes

N.O. max ER represents an extended-release nitric oxide precursor. Scientists now refer to nitric oxide (NO) as the "foundation" of cardiovascular health. This tiny molecule is a vasodilator responsible for controlling blood flow to the entire body, which may help support healthy blood flow pressure and promote the health of the endothelium-the inside of blood vessels. With age comes diminished NO levels; that's why since 1998, when three scientists won the Nobel Prize for their discovery of NO, researchers have been working to harness its heart-healthy activity. Today, with the application of XYMOGEN's extended-release technology, that activity has been realized with N.O. max ER.

Formulated to Exclude: Wheat, gluten, yeast, soy, fish, shellfish, peanuts, tree nuts, egg, sesame, ingredients derived from genetically modified organisms (GMOs), artificial colors, artificial sweeteners, and artificial preservatives.

Extended-Release Arginine Alpha-Ketoglutarate Clinically-Tested Ingredient

Additional Information

Storage: Keep closed in a cool, dry place out of reach of children.

ePV (ePedigree Verification) Third-Party Verified GMP Compliant

Scan to Learn More! This package is completely recyclable

Metadata

Product Details

UPC / SKU8 71149 00164 3
DSLD Entry Date2023-12-14
Product TypeOther Combinations
FormTablet or Pill
BrandXYMOGEN
DSLD ID303764
Data Updated2026-04-11
Research

Research Evidence

45
Research Sources
52
Avg Quality
12
Rct
11
Systematic Review
11
Meta Analysis
11
Clinical Trial
A Nitric oxide donors (nitrates), L-arginine, or nitric oxide synthase inhibitors for acute stroke
Meta Analysis The Cochrane database of systematic reviews 2017 PubMed DOI
A Arginine supplementation for prevention of necrotising enterocolitis in preterm infants
Meta Analysis The Cochrane database of systematic reviews 2017 PubMed DOI
B Nutritional interventions for treating foot ulcers in people with diabetes
Meta Analysis The Cochrane database of systematic reviews 2020 PubMed DOI
B Nitric oxide donors (nitrates), L-arginine, or nitric oxide synthase inhibitors for acute stroke
Systematic Review The Cochrane database of systematic reviews 2002 PubMed
B Arginine supplementation for prevention of necrotising enterocolitis in preterm infants
Systematic Review The Cochrane database of systematic reviews 2007 PubMed
B The Effect of Amino Acids on Wound Healing: A Systematic Review and Meta-Analysis on Arginine and Glutamine
Meta Analysis Nutrients 2021 PubMed DOI
B Nitric oxide donors (nitrates), L-arginine, or nitric oxide synthase inhibitors for acute ischaemic stroke
Systematic Review The Cochrane database of systematic reviews 2000 PubMed
B Dietary Supplements for Erectile Dysfunction: Analysis of Marketed Products, Systematic Review, Meta-Analysis and Rational Use
Meta Analysis Nutrients 2023 PubMed DOI
B Arginine supplementation for prevention of necrotising enterocolitis in preterm infants
Systematic Review The Cochrane database of systematic reviews 2004 PubMed
B An Analysis of Popular Online Erectile Dysfunction Supplements
Systematic Review The journal of sexual medicine 2019 PubMed DOI
View all evidence for L Arginine →
Compare

Similar Products

View all L Arginine products →

This product page is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before taking any supplement.